Objective To investigate the no reflow risk factors after percutaneous coronary intervention in
ST elevation myocardial infarction patients. Method Sample size, mean±standard deviation …

Discovered in 1987 as a potent endothelial cell–derived vasoconstrictor peptide, endothelin-
1 (ET-1), the predominant member of the endothelin peptide family, is now recognized as a …

What kind of a thing are chronic diseases? Are they objects, bundles of signs and symptoms,
properties, processes, or fictions? Rather than using concept analysis—the standard …

A cardiac transplant is an irreplaceable alternative for patients with terminal chronic heart
failure refractive to treatment. Heart failure results from an imbalance between cardiac output …

In the traditional medical model, physicians cure acute diseases using knowledge from the
basic biomedical sciences. With the rise of chronic disease and evidence-based medicine …

Chronic heart failure (CHF) is a global public health problem. Despite all the technical
advances available in modern cardiology, a medical strategy for the treatment of CHF has …

Пациенты с хронической сердечной недостаточности (ХСН) нередко имеют
желудочковые нарушения ритма, которые могут являться причиной внезапной …

In her defence of the alternative views on Lyme disease diagnosis behind Bill C-442,
Zubek1 is certainly right to focus on the patients in her response to CMAJ's article on Lyme …

Background: Despite gender differences in cardiovascular disease, data are limited on
whether sex-specific highsensitivity cardiac troponin (hs-cTn) cut-off values improve …

Background: Heart failure with reduced ejection fraction (HFrEF) has growing prevalence,
especially in postmenopausal females. Heart failure reversal therapy (HFRT) is a …